EBS - Emergent BioSolutions reaches 52-week low; down 43% YTD
- Emergent BioSolutions ( NYSE: EBS ) reached a new 52-week low of $26.79.
- Year to date, shares are down ~43% .
- In its Q2 financial results earlier in August, the company missed on the top and bottom line s.
- On August 10, Emergent ( EBS ) received a warning letter from the US FDA regarding conditions at a Baltimore facility .
For further details see:
Emergent BioSolutions reaches 52-week low; down 43% YTD